EV/EBITDA:
11.08+0.06(+0.54%)Summary
- As of today, HALO EV/EBITDA is 11.08, with a rise of +0.06 (+0.54%) during the current trading session.
- Over the past year, HALO EV/EBITDA has dropped by -2.08 (-15.81%).
- HALO EV/EBITDA is now -99.65% below its all-time high of 3171.43.
Performance
HALO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
HALO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +0.5% | +0.6% | +0.6% |
| 1M1 Month | -10.8% | -10.8% | -12.0% |
| 3M3 Months | +12.7% | +12.7% | +15.1% |
| 6M6 Months | -2.5% | +9.6% | +13.5% |
| YTDYTD | +6.5% | +28.5% | +39.7% |
| 1Y1 Year | -15.8% | +14.9% | +24.9% |
| 5Y5 Years | -87.6% | +122.6% | +132.2% |
HALO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 12.78 | -13.3% | 10.68 | +3.8% |
| 3M | 3-Month | 12.78 | -13.3% | 9.52 | +16.4% |
| 6M | 6-Month | 13.34 | -16.9% | 8.94 | +23.9% |
| 1Y | 1-Year | 14.83 | -25.3% | 8.94 | +23.9% |
| 3Y | 3-Year | 31.91 | -65.3% | 8.94 | +23.9% |
| 5Y | 5-Year | 134.51 | -91.8% | 8.94 | +23.9% |
| All-Time | All-Time | 3171.43 | -99.7% | -205.45 | +105.4% |
HALO EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 11.08(+6.5%) |
| 2024 | 10.40(-19.6%) |
| 2023 | 12.94(-53.8%) |
| 2022 | 28.00(+28.0%) |
| 2021 | 21.87(-42.3%) |
| 2020 | 37.89(+189.1%) |
| 2019 | -42.53(-33.7%) |
| 2018 | -31.82(-203.9%) |
| 2017 | 30.62(+288.4%) |
| 2016 | -16.25(+80.9%) |
| Date | Value |
|---|---|
| 2015 | -85.29(-361.8%) |
| 2014 | -18.47(+13.9%) |
| 2013 | -21.46(-63.8%) |
| 2012 | -13.10(+73.9%) |
| 2011 | -50.13(-270.8%) |
| 2010 | -13.52(-70.3%) |
| 2008 | -7.94(+52.0%) |
| 2007 | -16.55(+50.1%) |
| 2006 | -33.19(-389.5%) |
| 2005 | -6.78 |
FAQ
- What is Halozyme Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Halozyme Therapeutics, Inc.?
- What is HALO EV/EBITDA year-to-date change?
- What is Halozyme Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Halozyme Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of HALO is 11.08
What is the all-time high EV/EBITDA for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high EV/EBITDA is 3171.43
What is HALO EV/EBITDA year-to-date change?
Halozyme Therapeutics, Inc. EV/EBITDA has changed by +0.68 (+6.54%) since the beginning of the year
What is Halozyme Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, HALO EV/EBITDA has changed by -2.08 (-15.81%)